title: [Surgical treatment of pancreatic cancer].
abstract: Surgery remains the only hope for cure in pancreatic cancer. The most common procedures are reviewed. Postoperative morbidity and mortality below 30% and 5%, respectively, are the standard. The benefit of extended lymph node dissection and portal-mesenteric vein resection is dubious. Selected patients with locally advanced cancer may be down-staged with chemo-radiotherapy and eventually resected. Endoscopic stent placement is the preferred method to relieve biliary and/or gastrointestinal obstruction. The outcome is better for patients treated at high-volume centres than at smaller hospitals.
authors.affiliation: Gastroenheden, Herlev Hospital, 2730 Herlev, Denmark. maber@heh.regionh.dk
authors.forename: Magnus
authors.initials: M
authors.lastname: Bergenfeldt
authors.forename: Carsten Palnaes
authors.initials: CP
authors.lastname: Hansen
authors.forename: Michael Bau
authors.initials: MB
authors.lastname: Mortensen
mesh_terms: D006801:Humans; D010166:Palliative Care; D010179:Pancreas / Q000601:surgery; D010180:Pancreatectomy / Q000009:adverse effects / Q000379:methods; D010190:Pancreatic Neoplasms / Q000601:surgery*; D016577:Pancreaticoduodenectomy; D018579:Patient Selection; D016896:Treatment Outcome